Warning letter
Human Investigation Committee of Houston, Texas: warning letter of Jan 23, 2006
FDA warning letter UCM075770 · Center for Drug Evaluation and Research
Key facts
| Reference number | UCM075770 |
|---|---|
| Company | Human Investigation Committee of Houston, Texas |
| Subject | Institutional Review Board (IRB) |
| Issue date | Jan 23, 2006 |
| Posted date | Jan 23, 2006 |
| Issuing office | Center for Drug Evaluation and Research |
| Product type | Drugs |
| CFR sections cited | 56.111(a)(1), 56.108(b)(1), 56.111(a)(4), 50, 50.25(a)(2), 50.25(a)(4) |
| Country | 3 |
| Inspection city | Houston |
| Inspection ZIP | 77004-7212 |
| Inspection start date | May 2, 2005 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: